Earnings Release • Oct 21, 2013
Earnings Release
Open in ViewerOpens in native device viewer
Philips reports third-quarter comparable sales growth of 3% to EUR 5.6 billion; operational results improve by 33% to EUR 634 million
"This was anothersolid quarterfor Philips, especially in light of the challenging global economic environment. I am pleased with the 33% increase in our operational results, clearly reflecting the continuing benefits of our Accelerate! program. At Healthcare, EBITA improved while sales were flat and order intake declined by 2%. Consumer Lifestyle continued its strong sales performance with a comparable sales growth of 9%, driven by our focus on locally relevant products. At Lighting, LED-based sales grew 33% over the previous year, leading to an overall growth of 3%.
We continued to make good progress on the Accelerate! journey. Our overhead cost reduction program has resulted in EUR 856 million in total gross savings to date, including EUR 183 million realized in Q3 2013. Our End2End programs are delivering strong results. The leaning-out of the supply chain hasled to a reduction of inventory. Our Design for Excellence (DfX) program is building a strong funnel of opportunities to lower cost of goods sold in the coming years. End2End also enables us to deliver more locally relevant innovations faster to our customers. We see strong positive engagement from our employees, making us more agile and entrepreneurial.
Our strategic focus on value-accretive innovations and new business models is resulting in encouraging successes across our markets. Asthe leaderin the growing image-guided interventions and therapy market, Philips wasthe first company to install an advanced hybrid operating room in a leading medical institute in Moscow, which will serve as an example for other hospitals in Russia. Building on our leadership in digital innovation, we recently unveiled a range of higher-value connected consumer products,such as a smart air purifier, baby monitor and a digital grooming guide. As the global leader in energy-efficient lighting, we have been selected to transform Dubai Municipality's buildings with intelligent LED solutions. Our lighting solutions are saving 50% in electricity usage and will advance Dubai's mission to become the most sustainable city in the world.
We remain committed to reaching our financial targets this year. However, ongoing headwinds in the global economy are expected to continue to affect sales growth in the coming quarters.
Healthcare currency-comparable equipment orderintake declined by 2% year-on-year, with lower orderintake at Patient Care & Clinical Informatics, while Imaging Systems recorded a slight increase. Comparable sales were flat year-on-year. Growth at Customer Services, Home Healthcare Solutions and Patient Care & Clinical Informatics was offset by a decline at Imaging Systems. In growth geographies, comparable sales increased by 3%, with strong growth in China, Central & Eastern Europe and Latin America. EBITA margin excluding restructuring and acquisition-related charges increased by 2.0 percentage points year-on-year to 14.6%.
Consumer Lifestyle comparable sales increased by 9%, with all businesses, i.e. Health & Wellness, Domestic Appliances and Personal Care, recording good growth. In the growth geographies, comparable sales registered a strong double-digit increase. EBITA margin excluding restructuring and acquisition-related charges increased to 11.1%, a year-on-year improvement of 3.0 percentage points.
Lighting comparable sales increased by 3%, led by Lumileds, Automotive and Light Sources & Electronics. Comparable sales at Professional Lighting Solutions and Consumer Luminaires declined in the quarter. LED-based sales grew by 33% and now represent 30% of total Lighting sales. In the growth geographies, comparable sales showed a double-digit increase. EBITA margin excluding restructuring and acquisition-related charges was 10.2%, a year-on-year improvement of 3.9 percentage points.
The new EUR 1.5 billion share buy-back program starts on October 21.
Please refer to page 21 of this press release for more information about forward-looking statements, third-party market share data, use of non-GAAP information and use of fair-value measurements.
in millions of euros unless otherwise stated
| Q3 | Q3 | |
|---|---|---|
| 2012 | 2013 | |
| Sales | 5,821 | 5,618 |
| EBITA | 366 | 562 |
| as a % of sales | 6.3 | 10.0 |
| EBIT | 254 | 464 |
| as a % of sales | 4.4 | 8.3 |
| Financial income (expenses) | (116) | (92) |
| Income taxes | (37) | (108) |
| Results investments in associates | (6) | 6 |
| Net income from continuing operations | 95 | 270 |
| Discontinued operations | 10 | 11 |
| Net income | 105 | 281 |
| Net income attributable to shareholders per common share (in euros) - diluted |
0.11 | 0.31 |
in millions of euros unless otherwise stated
| Q3 | Q3 | % change | ||
|---|---|---|---|---|
| 2012 | 2013 | nominal comparable | ||
| Healthcare | 2,443 | 2,258 | (8) | 0 |
| Consumer Lifestyle | 1,051 | 1,091 | 4 | 9 |
| Lighting | 2,139 | 2,084 | (3) | 3 |
| Innovation, Group & | ||||
| Services | 188 | 185 | (2) | (7) |
| Philips Group | 5,821 | 5,618 | (3) | 3 |
in millions of euros unless otherwise stated
| Q3 | Q3 | % change | ||
|---|---|---|---|---|
| 2012 | 2013 | nominal comparable | ||
| Western Europe | 1,402 | 1,382 | (1) | (1) |
| North America | 1,852 | 1,710 | (8) | (2) |
| Other mature geographies | 524 | 434 | (17) | (1) |
| Total mature geographies | 3,778 | 3,526 | (7) | (1) |
| Growth geographies | 2,043 | 2,092 | 2 | 10 |
| Philips Group | 5,821 | 5,618 | (3) | 3 |
in millions of euros
| Q3 | Q3 | |
|---|---|---|
| 2012 | 2013 | |
| Healthcare | 305 | 329 |
| Consumer Lifestyle | 78 | 116 |
| Lighting | 32 | 177 |
| Innovation, Group & Services | (49) | (60) |
| Philips Group | 366 | 562 |
as a % of sales
| Q3 | Q3 | |
|---|---|---|
| 2012 | 2013 | |
| Healthcare | 12.5 | 14.6 |
| Consumer Lifestyle | 7.4 | 10.6 |
| Lighting | 1.5 | 8.5 |
| Innovation, Group & Services | (26.1) | (32.4) |
| Philips Group | 6.3 | 10.0 |
in millions of euros
| Q3 | Q3 | |
|---|---|---|
| 2012 | 2013 | |
| Healthcare | (3) | (1) |
| Consumer Lifestyle | (7) | (5) |
| Lighting | (68) | (36) |
| Innovation, Group & Services | 2 | 1 |
| Philips Group | (76) | (41) |
in millions of euros unless otherwise stated
| Q3 | Q3 |
|---|---|
| 2012 | 2013 |
| 255 | 283 |
| 63 | 102 |
| (14) | 140 |
| (50) | (61) |
| 254 | 464 |
| 4.4 | 8.3 |
| Q3 | Q3 | |
|---|---|---|
| 2012 | 2013 | |
| Net interest expenses | (85) | (61) |
| Value adjustment to option in the UK pension plan |
(12) | (12) |
| Other | (19) | (19) |
| (116) | (92) |
in millions of euros
| Q3 | Q3 | |
|---|---|---|
| 2012 | 2013 | |
| Beginning cash balance | 3,134 | 2,307 |
| Free cash flow | 410 | 117 |
| Net cash flow from operating activities | 648 | 337 |
| Net capital expenditures | (238) | (220) |
| Acquisitions of businesses | (18) | (5) |
| Other cash flow from investing activities | (18) | (6) |
| Treasury shares transactions | (135) | (18) |
| Dividend paid | 1 | (41) |
| Changes in debt/other | (142) | (237) |
| Net cash flow discontinued operations | − | (83) |
| Ending balance | 3,232 | 2,034 |
in millions of euros
• Financial income and expenses amounted to a net expense of EUR 92 million, an improvement of EUR 24 million compared with Q3 2012. This was mainly attributable to lower interest expenses on debt.
• Operating activitiesresulted in a cash inflow of EUR 337 million, compared to an inflow of EUR 648 million in Q3 2012. The Q3 2013 figure includes a net increase in working capital of EUR 357 million, compared to a net decrease in working capital of EUR 139 million in Q3 2012. The remaining difference compared to Q3 2012 is mainly attributable to higher earnings.
in millions of euros
Inventories
1) sales is calculated over the preceding 12 months
• Gross capital expenditures on property, plant and equipment were EUR 7 million lower than in Q3 2012, mainly due to lower investments at Lighting and IG&S.
1) Number of employees excludes discontinued operations. Discontinued operations, comprising the Audio, Video, Multimedia and Accessories business, had 1,940 employees at end of Q3 2013 (Q3 2012: 2,058; Q2 2013: 1,958).
in millions of euros unless otherwise stated
| Q3 | Q3 | |
|---|---|---|
| 2012 | 2013 | |
| Sales | 2,443 | 2,258 |
| Sales growth | ||
| % nominal | 18 | (8) |
| % comparable | 7 | 0 |
| EBITA | 305 | 329 |
| as a % of sales | 12.5 | 14.6 |
| EBIT | 255 | 283 |
| as a % of sales | 10.4 | 12.5 |
| Net operating capital (NOC) | 8,261 | 7,525 |
| Number of employees (FTEs) | 38,228 | 37,569 |
in millions of euros
EBITA
• Currency-comparable equipment orders declined 2% year-on-year. Patient Care & Clinical Informatics recorded a 7% decline, while Imaging Systems showed low-single-digit growth. Equipment order intake in growth geographies showed a low-single-digit decline, mainly due to Russia & Central Asia, while China and India recorded double-digit growth. North America equipment order intake showed a low-single-digit decline. Western Europe recorded a 7% decline as Q3 2012 included large and multi-year deals in the Netherlands and UK.
• Restructuring and acquisition-related charges in Q4 2013 are expected to total approximately EUR 5 million.
*Excluding the Audio, Video, Multimedia and Accessories business
in millions of euros unless otherwise stated
| Q3 | Q3 | |
|---|---|---|
| 2012 | 2013 | |
| Sales | 1,051 | 1,091 |
| Sales growth | ||
| % nominal | 18 | 4 |
| % comparable | 10 | 9 |
| EBITA | 78 | 116 |
| as a % of sales | 7.4 | 10.6 |
| EBIT | 63 | 102 |
| as a % of sales | 6.0 | 9.3 |
| Net operating capital (NOC) | 1,443 | 1,164 |
| Number of employees (FTEs) | 17,125 | 16,326 |
in millions of euros
200
■-EBITA in millions of euros----EBITA as a % of sales
EBITA amounted to EUR 116 million, or 10.6% of sales, an increase of EUR 38 million and 3.2 percentage points compared to Q3 2012.
Excluding restructuring and acquisition-related charges, EBITA was EUR 121 million, or 11.1% of sales, compared to EUR 85 million, or 8.1% of sales, in Q3 2012. The improvement of 3.0 percentage points was largely attributable to operating leverage from higher sales and improved gross margins across all businesses.
• Restructuring and acquisition-related charges in Q4 2013 are expected to total approximately EUR 5 million.
in millions of euros unless otherwise stated
| Q3 | Q3 | |
|---|---|---|
| 2012 | 2013 | |
| Sales | 2,139 | 2,084 |
| Sales growth | ||
| % nominal | 13 | (3) |
| % comparable | 4 | 3 |
| EBITA | 32 | 177 |
| as a % of sales | 1.5 | 8.5 |
| EBIT | (14) | 140 |
| as a % of sales | (0.7) | 6.7 |
| Net operating capital (NOC) | 5,051 | 4,668 |
| Number of employees (FTEs) | 51,751 | 47,875 |
in millions of euros
EBITA
EBITA amounted to EUR 177 million, compared to EUR 32 million in Q3 2012. Earnings in Q3 2013 were impacted by restructuring and acquisition-related charges of EUR 36 million (Q3 2012: EUR 102 million, including a EUR 34 million loss on the sale of industrial assets). The year-on-year EBITA increase was driven by higher gross margins and improvements in the cost structure.
EBITA, excluding restructuring and acquisition-related charges and other losses, was EUR 213 million, or 10.2% of sales (Q3 2012: EUR 134 million, or 6.3% of sales). Light Sources & Electronics, Professional Lighting Solutions and Lumileds were the main contributors to the operational improvement.
• Restructuring and acquisition-related charges in Q4 2013 are expected to total approximately EUR 20 million.
in millions of euros unless otherwise stated
| Q3 | Q3 | |
|---|---|---|
| 2012 | 2013 | |
| Sales | 188 | 185 |
| Sales growth | ||
| % nominal | 19 | (2) |
| % comparable | 16 | (7) |
| EBITA of: | ||
| Group Innovation | (33) | (28) |
| IP Royalties | 63 | 82 |
| Group and Regional Costs | (38) | (33) |
| Accelerate! investments | (33) | (34) |
| Pensions | 1 | (32) |
| Service Units and Other | (9) | (15) |
| EBITA | (49) | (60) |
| EBIT | (50) | (61) |
| Net operating capital (NOC) | (3,707) | (3,108) |
| Number of employees (FTEs) | 12,122 | 12,556 |
in millions of euros
EBITA of Service Units and Other included EUR 19 million of net costs formerly reported in discontinued businesses (Q3 2012 included EUR 9 million related to the Audio, Video, Multimedia and Accessories business and EUR 3 million related to the Television business).
Compared to Q3 2012, the number of employees increased by 434, primarily due to the centralization of Human Resource and Research activities, partly offset by restructuring activities in the Service Units.
• Restructuring charges in Q4 2013 are expected to total approximately EUR 5 million.
in millions of euros unless otherwise stated
| Q3 | Q3 | |
|---|---|---|
| 2012 | 2013 | |
| EBITA | 2 | (9) |
| Disentanglement costs | 0 | (12) |
| Former AVM&A net costs allocated to Consumer Lifestyle |
9 | 7 |
| Former AVM&A net costs allocated to IG&S | 9 | 19 |
| Eliminated amortization other AVM&A intangibles |
(4) | 0 |
| EBIT discontinued operations | 16 | 5 |
| Financial income and expenses | 0 | 1 |
| Income taxes | (6) | 4 |
| Net income (loss) of discontinued operations |
10 | 10 |
| Number of employees (FTEs) | 2,058 | 1,940 |
Following the agreement with Funai Electric Co. Ltd, as mentioned in the Q1 2013 pressrelease, the results of the Audio, Video, Multimedia and Accessories (AVM&A) business are reported as discontinued operations in the Consolidated statements of income and Consolidated statements of cash flows. Prior-period comparative figures have been restated accordingly. Consequently, Audio, Video, Multimedia and Accessories sales and EBITA are no longer included in the Consumer Lifestyle and Group results of continuing operations.
The net income of discontinued operations attributable to the Audio, Video, Multimedia and Accessories business is in line with Q3 2012 at EUR 10 million.
Since Q1 2013, the applicable net operating capital of this business is reported under Assets and Liabilities classified as held for sale in the Consolidated balance sheet.
The EBITA of Consumer Lifestyle includes net costs of EUR 7 million formerly reported as part of the results of this business. The EBITA of Innovation, Group & Services includes net costs of EUR 19 million formerly reported as part of this business.
Philips will start a share repurchase program of up to EUR 1.5 billion to be executed during the next 2-3 years. The maximum number of shares that will be repurchased under this program depends on the development in the share price during the course of the program. All shares repurchased under this program will be cancelled, resulting in a reduction of Philips' outstanding share capital.
Philips willstart thisrepurchase program as of October 21 and will enter into subsequent discretionary management agreements with one or more banks to repurchase Philips shares within the limits ofrelevant laws and regulations(in particular EC Regulation 2273/2003) and Philips' articles of association. All transactions under this program will be published on Philips' website (www.philips.com/investor) on a weekly basis.
all amounts in millions of euros unless otherwise stated
| 2012 | 2013 | |||||||
|---|---|---|---|---|---|---|---|---|
| 1st quarter | 2nd quarter | 3rd quarter | 4th quarter | 1st quarter | 2nd quarter | 3rd quarter | 4th quarter | |
| Sales | 5,307 | 5,570 | 5,821 | 6,759 | 5,258 | 5,654 | 5,618 | |
| comparable sales growth % | 5 | 6 | 7 | 5 | 1 | 3 | 3 | |
| Gross margin | 2,008 | 2,139 | 2,253 | 2,591 | 2,101 | 2,347 | 2,357 | |
| as a % of sales | 37.8 | 38.4 | 38.7 | 38.3 | 40.0 | 41.5 | 42.0 | |
| Selling expenses | (1,196) | (1,314) | (1,298) | (1,526) | (1,190) | (1,245) | (1,214) | |
| as a % of sales | (22.5) | (23.6) | (22.3) | (22.6) | (22.6) | (22.0) | (21.6) | |
| G&A expenses | (199) | (151) | (222) | (273) | (200) | (230) | (253) | |
| as a % of sales | (3.7) | (2.7) | (3.8) | (4.0) | (3.8) | (4.1) | (4.5) | |
| R&D expenses | (450) | (440) | (447) | (494) | (424) | (416) | (437) | |
| as a % of sales | (8.5) | (7.9) | (7.7) | (7.3) | (8.1) | (7.4) | (7.8) | |
| EBIT | 341 | 229 | 254 | (176) | 305 | 509 | 464 | |
| as a % of sales | 6.4 | 4.1 | 4.4 | (2.6) | 5.8 | 9.0 | 8.3 | |
| EBITA | 451 | 339 | 366 | (50) | 402 | 603 | 562 | |
| as a % of sales | 8.5 | 6.1 | 6.3 | (0.7) | 7.6 | 10.7 | 10.0 | |
| Net income (loss) | 183 | 102 | 105 | (420) | 162 | 317 | 281 | |
| Net income (loss) attributable to shareholders |
182 | 102 | 104 | (423) | 161 | 317 | 282 | |
| Net income (loss) - shareholders per common share in euros - diluted |
0.20 | 0.11 | 0.11 | (0.46) | 0.17 | 0.35 | 0.31 |
all amounts in millions of euros unless otherwise stated
| 2012 | 2013 | |||||||
|---|---|---|---|---|---|---|---|---|
| January March |
January June |
January September |
January December |
January March |
January June |
January September |
January December |
|
| Sales comparable sales growth % |
5,307 5 |
10,877 6 |
16,698 6 |
23,457 6 |
5,258 1 |
10,912 2 |
16,530 2 |
|
| Gross margin as a % of sales |
2,008 37.8 |
4,147 38.1 |
6,400 38.3 |
8,991 38.3 |
2,101 40.0 |
4,448 40.8 |
6,805 41.2 |
|
| Selling expenses as a % of sales |
(1,196) (22.5) |
(2,510) (23.1) |
(3,808) (22.8) |
(5,334) (22.7) |
(1,190) (22.6) |
(2,435) (22.3) |
(3,649) (22.1) |
|
| G&A expenses as a % of sales |
(199) (3.7) |
(350) (3.2) |
(572) (3.4) |
(845) (3.6) |
(200) (3.8) |
(430) (3.9) |
(683) (4.1) |
|
| R&D expenses | (450) | (890) | (1,337) | (1,831) | (424) | (840) | (1,277) | |
| as a % sales | (8.5) | (8.2) | (8.0) | (7.8) | (8.1) | (7.7) | (7.7) | |
| EBIT | 341 | 570 | 824 | 648 | 305 | 814 | 1,278 | |
| as a % of sales | 6.4 | 5.2 | 4.9 | 2.8 | 5.8 | 7.5 | 7.7 | |
| EBITA | 451 | 790 | 1,156 | 1,106 | 402 | 1,005 | 1,567 | |
| as a % of sales | 8.5 | 7.3 | 6.9 | 4.7 | 7.6 | 9.2 | 9.5 | |
| Net income (loss) | 183 | 285 | 390 | (30) | 162 | 479 | 760 | |
| Net income (loss) attributable to shareholders |
182 | 284 | 388 | (35) | 161 | 478 | 760 | |
| Net income (loss) - shareholders per common share in euros - diluted |
0.20 | 0.31 | 0.42 | (0.04) | 0.17 | 0.52 | 0.83 | |
| Net income (loss) from continuing operations as a % of shareholders' equity |
6.3 | 4.3 | 4.0 | (0.6) | 5.8 | 9.0 | 9.4 | |
| period ended 2012 | period ended 2013 | |||||||
| Number of common shares outstanding (after deduction of treasury shares) at the |
||||||||
| end of period (in thousands) | 915,926 | 931,391 | 923,912 | 914,591 | 905,381 | 913,874 | 915,095 | |
| Shareholders' equity per common share in euros |
13.35 | 13.01 | 13.01 | 12.19 | 12.33 | 11.78 | 11.93 | |
| Inventories as a % of sales1) | 16.9 | 17.2 | 16.9 | 14.3 | 15.5 | 15.7 | 16.5 | |
| Inventories excluding discontinued operations |
3,623 | 3,812 | 3,877 | 3,359 | 3,629 | 3,696 | 3,832 | |
| Net debt : group equity ratio | 6:94 | 13:87 | 11:89 | 6:94 | 12:88 | 16:84 | 16:84 | |
| Net operating capital | 10,634 | 11,485 | 11,048 | 9,316 | 9,969 | 10,184 | 10,249 | |
| Total employees of which discontinued operations |
122,008 2,285 |
121,801 2,166 |
121,284 2,058 |
118,087 2,005 |
117,881 1,970 |
117,239 1,958 |
116,266 1,940 |
1) sales is calculated over the preceding 12 months
This document and the related oral presentation, including responses to questions following the presentation, contain certain forward-looking statements with respect to the financial condition, results of operations and business of Philips and certain of the plans and objectives of Philips with respect to these items. Examples of forward-looking statements include statements made about our strategy, estimates of sales growth, future EBITA and future developments in our organic business. By their nature, these statements involve risk and uncertainty because they relate to future events and circumstances and there are many factors that could cause actual results and developments to differ materially from those expressed or implied by these statements.
These factors include but are not limited to domestic and global economic and business conditions, developments within the euro zone, the successful implementation of our strategy and our ability to realize the benefits of this strategy, our ability to develop and market new products, changes in legislation, legal claims, changes in exchange and interest rates, changes in tax rates, pension costs and actuarial assumptions, raw materials and employee costs, our ability to identify and complete successful acquisitions and to integrate those acquisitions into our business, our ability to successfully exit certain businesses or restructure our operations, the rate of technological changes, political, economic and other developments in countries where Philips operates, industry consolidation and competition. As a result, Philips' actual future results may differ materially from the plans, goals and expectations set forth in such forward-looking statements. For a discussion of factors that could cause future results to differ from such forward-looking statements, see the Risk management chapter included in our Annual Report 2012.
Statements regarding market share, including those regarding Philips' competitive position, contained in this document are based on outside sources such as research institutes, industry and dealer panels in combination with management estimates. Where information is not yet available to Philips, those statements may also be based on estimates and projections prepared by outside sources or management. Rankings are based on sales unless otherwise stated.
In presenting and discussing the Philips Group financial position, operating results and cash flows, management uses certain non-GAAP financial measures. These non-GAAP financial measures should not be viewed in isolation as alternatives to the equivalent IFRS measures and should be used in conjunction with the most directly comparable IFRS measures. A reconciliation of these non-GAAP measures to the most directly comparable IFRS measures is contained in this document. Further information on non-GAAP measures can be found in our Annual Report 2012.
In presenting the Philips Group financial position, fair values are used for the measurement of various items in accordance with the applicable accounting standards. These fair values are based on market prices, where available, and are obtained from sources that are deemed to be reliable. Readers are cautioned that these values are subject to changes over time and are only valid at the balance sheet date. When quoted prices or observable market data are not readily available, fair values are estimated using appropriate valuation models and unobservable inputs. Such fair value estimates require management to make significant assumptions with respect to future developments, which are inherently uncertain and may therefore deviate from actual developments. Critical assumptions used are disclosed in our Annual Report 2012. Independent valuations may have been obtained to support management's determination of fair values.
All amounts are in millions of euros unless otherwise stated. All reported data is unaudited. Financial reporting is in accordance with the accounting policies as stated in the Annual Report 2012, unless otherwise stated.
Prior-period financials have been restated for the treatment of Audio, Video, Multimedia and Accessories as discontinued operations, the adoption of IAS 19R, which mainly relates to pension reporting, and adjustments to the quarterly figures of 2012, which have already been included in the Annual Report 2012 (for an explanation refer to Annual Report 2012 section 12.10 "Significant Accounting Policies"). An overview of the revised 2012 figures per quarter is available on the Philips website, in the Investor Relations section.
in millions of euros unless otherwise stated
| 3rd quarter | January to September | |||
|---|---|---|---|---|
| 2012 | 2013 | 2012 | 2013 | |
| Sales | 5,821 | 5,618 | 16,698 | 16,530 |
| Cost of sales | (3,568) | (3,261) | (10,298) | (9,725) |
| Gross margin | 2,253 | 2,357 | 6,400 | 6,805 |
| Selling expenses | (1,298) | (1,214) | (3,808) | (3,649) |
| General and administrative expenses | (222) | (253) | (572) | (683) |
| Research and development expenses | (447) | (437) | (1,337) | (1,277) |
| Other business income | 9 | 20 | 241 | 102 |
| Other business expenses | (41) | (9) | (100) | (20) |
| Income from operations | 254 | 464 | 824 | 1,278 |
| Financial income | 13 | 15 | 62 | 51 |
| Financial expenses | (129) | (107) | (352) | (304) |
| Income before taxes | 138 | 372 | 534 | 1,025 |
| Income tax expense | (37) | (108) | (158) | (298) |
| Income after taxes | 101 | 264 | 376 | 727 |
| Results relating to investments in associates | (6) | 6 | (18) | 21 |
| Net income from continuing operations | 95 | 270 | 358 | 748 |
| Discontinued operations - net of income tax | 10 | 11 | 32 | 12 |
| Net income | 105 | 281 | 390 | 760 |
| Attribution of net income for the period | ||||
| Net income attributable to shareholders | 104 | 282 | 388 | 760 |
| Net income attributable to non-controlling interests | 1 | (1) | 2 | − |
| Earnings per common share attributable to shareholders | ||||
| Weighted average number of common shares outstanding (after deduction of treasury shares) during the period (in thousands): |
||||
| - basic | 929,2611) | 914,431 | 925,1121) | 910,145 |
| - diluted | 936,1761) | 922,209 | 929,4851) | 917,701 |
| Net income attributable to shareholders per common share in euros: | ||||
| - basic | 0.11 | 0.31 | 0.42 | 0.84 |
| - diluted | 0.11 | 0.31 | 0.42 | 0.83 |
1) Adjusted to make 2012 comparable for the elective share dividend premium (273 thousand) issued in June 2013
in millions of euros unless otherwise stated
| September 30, | December 31, | September 29, | |
|---|---|---|---|
| 2012 | 2012 | 2013 | |
| Non-current assets: Property, plant and equipment |
2,992 | 2,959 | 2,813 |
| Goodwill | 7,117 | 6,948 | 6,654 |
| Intangible assets excluding goodwill | 3,902 | 3,731 | 3,400 |
| Non-current receivables | 154 | 176 | 163 |
| Investments in associates | 195 | 177 | 165 |
| Other non-current financial assets | 557 | 549 | 596 |
| Deferred tax assets | 1,837 | 1,919 | 1,826 |
| Other non-current assets | 80 | 94 | 67 |
| Total non-current assets | 16,834 | 16,553 | 15,684 |
| Current assets: | |||
| Inventories - net | 4,071 | 3,495 | 3,832 |
| Other current financial assets | − | − | 10 |
| Other current assets | 412 | 337 | 425 |
| Derivative financial assets | 129 | 137 | 138 |
| Income tax receivable | 133 | 97 | 136 |
| Receivables | 4,522 | 4,585 | 4,580 |
| Assets classified as held for sale | 56 | 43 | 486 |
| Cash and cash equivalents | 3,232 | 3,834 | 2,034 |
| Total current assets | 12,555 | 12,528 | 11,641 |
| Total assets | 29,389 | 29,081 | 27,325 |
| Shareholders' equity | 12,016 | 11,151 | 10,913 |
| Non-controlling interests | 36 | 34 | 38 |
| Group equity | 12,052 | 11,185 | 10,951 |
| Non-current liabilities: | |||
| Long-term debt | 3,837 | 3,725 | 3,374 |
| Long-term provisions | 1,969 | 2,119 | 2,011 |
| Deferred tax liabilities | 144 | 92 | 104 |
| Other non-current liabilities | 1,955 | 2,005 | 1,754 |
| Total non-current liabilities | 7,905 | 7,941 | 7,243 |
| Current liabilities: | |||
| Short-term debt | 859 | 809 | 692 |
| Derivative financial liabilities | 674 | 517 | 413 |
| Income tax payable | 142 | 200 | 119 |
| Accounts and notes payable | 2,997 | 2,839 | 3,076 |
| Accrued liabilities | 2,986 | 3,171 | 2,895 |
| Short-term provisions | 640 | 837 | 613 |
| Liabilities directly associated with assets held for sale | 33 | 27 | 245 |
| Other current liabilities | 1,101 | 1,555 | 1,078 |
| Total current liabilities | 9,432 | 9,955 | 9,131 |
| Total liabilities and group equity | 29,389 | 29,081 | 27,325 |
in millions of euros
| 3rd quarter | January to September | |||
|---|---|---|---|---|
| 2012 | 2013 | 2012 | 2013 | |
| Cash flows from operating activities: | ||||
| Net income | 105 | 281 | 390 | 760 |
| Loss from discontinued operations | (10) | (11) | (32) | (12) |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Fixed assets depreciation, amortization, and impairments | 346 | 330 | 1,016 | 946 |
| Impairment of goodwill and other non-current financial assets | 9 | 3 | 12 | 6 |
| Net gain (loss) on sale of assets | 33 | (9) | (159) | (49) |
| (Income) loss from investments in associates | 3 | (7) | 9 | (22) |
| Dividends received from investments in associates | − | − | 7 | 6 |
| (Increase) decrease in working capital: | 139 | (357) | (234) | (1,247) |
| Increase in receivables and other current assets | (206) | (428) | (109) | (421) |
| Increase in inventories | (157) | (265) | (443) | (662) |
| Increase (decrease) in accounts payable, accrued and other liabilities | 502 | 336 | 318 | (164) |
| (Increase) decrease in non-current receivables, other assets and other liabilities | (62) | 60 | (191) | (79) |
| Increase (decrease) in provisions | 51 | (76) | 107 | (243) |
| Other items | 34 | 123 | 101 | 167 |
| Net cash provided by operating activities | 648 | 337 | 1,026 | 233 |
| Cash flows from investing activities: | ||||
| Purchase of intangible assets | (11) | (9) | (25) | (17) |
| Proceeds from sale of intangible assets | − | − | 160 | − |
| Expenditures on development assets | (86) | (88) | (250) | (268) |
| Capital expenditures on property, plant and equipment | (144) | (137) | (449) | (406) |
| Proceeds from disposals of property, plant and equipment | 3 | 14 | 412 | 22 |
| Cash to derivatives and securities | (9) | (11) | (54) | (93) |
| Purchase of other non-current financial assets | (9) | (1) | (163) | (5) |
| Proceeds from other non-current financial assets | − | 6 | − | 15 |
| Purchase of businesses, net of cash acquired | (22) | 1 | (253) | (5) |
| Proceeds from sale of interests in businesses, net of cash disposed of | 4 | (6) | 13 | 85 |
| Net cash used for investing activities | (274) | (231) | (609) | (672) |
| Cash flows from financing activities: | ||||
| Proceeds from issuance of (payments on) short-term debt | (20) | (76) | 168 | (203) |
| Principal payments on long-term debt | (106) | (126) | (589) | (167) |
| Proceeds from issuance of long-term debt | 28 | 14 | 1,201 | 48 |
| Treasury shares transactions | (135) | (18) | (577) | (505) |
| Dividends paid | 1 | (41) | (255) | (272) |
| Net cash used for financing activities | (232) | (247) | (52) | (1,099) |
| Net cash provided by (used for) continuing operations | 142 | (141) | 365 | (1,538) |
| Cash flows from discontinued operations: | ||||
| Net cash used for operating activities | (70) | (44) | (273) | (176) |
| Net cash provided by (used for) investing activities | 70 | (39) | 73 | (50) |
| Net cash used for discontinued operations | − | (83) | (200) | (226) |
| Net cash provided by (used for) continuing and discontinued operations | 142 | (224) | 165 | (1,764) |
| 3rd quarter | January to September | |||
|---|---|---|---|---|
| Effect of change in exchange rates on cash and cash equivalents | (44) | (49) | (80) | (36) |
| Cash and cash equivalents at the beginning of the period | 3,134 | 2,307 | 3,147 | 3,834 |
| Cash and cash equivalents at the end of the period | 3,232 | 2,034 | 3,232 | 2,034 |
| Net cash paid during the period for | ||||
| Pensions | (149) | (157) | (490) | (489) |
| Interest | (102) | (83) | (210) | (202) |
| Income taxes | (92) | (139) | (275) | (378) |
For a number of reasons, principally the effects of translation differences, certain items in the statements of cash flows do not correspond to the differences between the balance sheet amounts for the respective items.
in millions of euros
| common shares |
capital in excess of par value |
retained earnings |
revaluation reserve |
currency translation differences |
available -for-sale financial assets |
cash flow hedges |
treasury shares at cost |
total sharehol ders' equity |
non controlling interests |
total equity |
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| January-September 2013 | |||||||||||
| Balance as of December 31, 2012 |
191 | 1,304 | 10,724 | 54 | (93) | 54 | 20 | (1,103) | 11,151 | 34 | 11,185 |
| Net income | 760 | 760 | − | 760 | |||||||
| Other comprehensive income, net of tax |
(24) | (12) | (277) | 8 | (6) | (311) | (311) | ||||
| Total comprehensive income |
736 | (12) | (277) | 8 | (6) | 449 | − | 449 | |||
| Dividend distributed | 4 | 402 | (678) | (272) | (272) | ||||||
| Movement non-controlling interest |
− | − | 4 | 4 | |||||||
| Cancellation of treasury shares |
(7) | (780) | 787 | − | − | ||||||
| Purchase of treasury shares | (38) | (531) | (569) | (569) | |||||||
| Re-issuance of treasury shares |
(37) | (58) | 167 | 72 | 72 | ||||||
| Share-based compensation plans |
74 | 74 | 74 | ||||||||
| Income tax share-based compensation plans |
8 | 8 | 8 | ||||||||
| Total other equity movements |
(3) | 447 | (1,554) | 423 | (687) | 4 | (683) | ||||
| Balance as of September 29, 2013 |
188 | 1,751 | 9,906 | 42 | (370) | 62 | 14 | (680) | 10,913 | 38 | 10,951 |
in millions of euros unless otherwise stated
| 3rd quarter | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2012 | |||||||||
| sales | income from operations | sales | income from operations | ||||||
| as a % of sales | as a % of sales | ||||||||
| Healthcare | 2,443 | 255 | 10.4 | 2,258 | 283 | 12.5 | |||
| Consumer Lifestyle | 1,051 | 63 | 6.0 | 1,091 | 102 | 9.3 | |||
| Lighting | 2,139 | (14) | (0.7) | 2,084 | 140 | 6.7 | |||
| Innovation, Group & Services | 188 | (50) | − | 185 | (61) | − | |||
| Philips Group | 5,821 | 254 | 4.4 | 5,618 | 464 | 8.3 |
| January to September | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2012 | 2013 | ||||||||
| sales | income from operations | income from operations | |||||||
| as a % of sales | as a % of sales | ||||||||
| Healthcare | 7,065 | 665 | 9.4 | 6,747 | 838 | 12.4 | |||
| Consumer Lifestyle | 2,934 | 287 | 9.8 | 3,177 | 255 | 8.0 | |||
| Lighting | 6,180 | 22 | 0.4 | 6,107 | 365 | 6.0 | |||
| Innovation, Group & Services | 519 | (150) | − | 499 | (180) | − | |||
| Philips Group | 16,698 | 824 | 4.9 | 16,530 | 1,278 | 7.7 |
in millions of euros
| sales | total assets | total liabilities excluding debt | |||||
|---|---|---|---|---|---|---|---|
| January to September September 30, |
September 29, | September 30, | September 29, | ||||
| 2012 | 2013 | 2012 | 2013 | 2012 | 2013 | ||
| Healthcare | 7,065 | 6,747 | 11,617 | 10,783 | 3,269 | 3,172 | |
| Consumer Lifestyle | 2,934 | 3,177 | 3,506 | 3,007 | 2,063 | 1,843 | |
| Lighting | 6,180 | 6,107 | 7,316 | 7,150 | 2,243 | 2,461 | |
| Innovation, Group & Services | 519 | 499 | 6,894 | 5,899 | 5,033 | 4,587 | |
| 29,333 | 26,839 | 12,608 | 12,063 | ||||
| Assets and liabilities classified as held for | |||||||
| sale | 56 | 486 | 33 | 245 | |||
| Philips Group | 16,698 | 16,530 | 29,389 | 27,325 | 12,641 | 12,308 |
| sales | tangible and intangible assets1) | |||
|---|---|---|---|---|
| January to September | September 30, | September 29, | ||
| 2012 | 2013 | 2012 | 2013 | |
| Netherlands | 436 | 463 | 892 | 867 |
| United States | 4,974 | 4,699 | 8,280 | 7,572 |
| China | 1,847 | 2,045 | 1,122 | 1,093 |
| Germany | 914 | 926 | 261 | 282 |
| Japan | 842 | 761 | 621 | 439 |
| France | 663 | 633 | 89 | 82 |
| India | 520 | 493 | 156 | 126 |
| Other countries | 6,502 | 6,510 | 2,590 | 2,406 |
| Philips Group | 16,698 | 16,530 | 14,011 | 12,867 |
1) Includes property, plant and equipment, goodwill, and intangible assets excluding goodwill
in millions of euros
| 3rd quarter | ||||||
|---|---|---|---|---|---|---|
| 2012 | 2013 | |||||
| Netherlands | other | total | Netherlands | other | total | |
| Defined-benefit plans | ||||||
| Pensions | ||||||
| Current service cost | 44 | 21 | 65 | 48 | 23 | 71 |
| Past service cost (incl. curtailments) | − | − | − | − | − | − |
| Settlements | − | − | − | − | 31 | 31 |
| Interest expense | − | 19 | 19 | − | 17 | 17 |
| Interest income | (1) | − | (1) | (1) | − | (1) |
| Total | 43 | 40 | 83 | 47 | 71 | 118 |
| of which discontinued operations | − | − | − | − | − | − |
| Retiree Medical | ||||||
| Interest expense | − | 3 | 3 | − | 2 | 2 |
| Total | − | 3 | 3 | − | 2 | 2 |
| Defined-contribution plans | ||||||
| Cost | 3 | 34 | 37 | 3 | 34 | 37 |
| of which discontinued operations | − | 1 | 1 | − | 1 | 1 |
| January to September | ||||||
|---|---|---|---|---|---|---|
| 2012 | 2013 | |||||
| Netherlands | other | total | Netherlands | other | total | |
| Defined-benefit plans | ||||||
| Pensions | ||||||
| Current service cost | 131 | 65 | 196 | 144 | 64 | 208 |
| Past service cost (incl. curtailments) | − | − | − | − | (78) | (78) |
| Settlements | − | − | − | − | 31 | 31 |
| Interest expense | − | 57 | 57 | − | 49 | 49 |
| Interest income | (3) | − | (3) | (3) | − | (3) |
| Total | 128 | 122 | 250 | 141 | 66 | 207 |
| of which discontinued operations | 1 | 1 | 2 | 1 | − | 1 |
| Retiree Medical | ||||||
| Current service cost | − | 1 | 1 | − | 1 | 1 |
| Past service cost (incl. curtailments) | − | (25) | (25) | − | − | − |
| Interest expense | − | 9 | 9 | − | 8 | 8 |
| Total | − | (15) | (15) | − | 9 | 9 |
| Defined-contribution plans | ||||||
| Cost | 8 | 101 | 109 | 7 | 105 | 112 |
| of which discontinued operations | 1 | 3 | 4 | − | 2 | 2 |
in millions of euros unless otherwise stated
Certain non-GAAP financial measures are presented when discussing the Philips Group's performance. In the following tables, a reconciliation to the most directly comparable IFRS performance measure is made.
| in % | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3rd quarter | January to September | |||||||||
| comparable growth |
currency effects |
consolidation changes |
nominal growth |
comparable growth |
currency effects |
consolidation changes |
nominal growth |
|||
| 2013 versus 2012 | ||||||||||
| Healthcare | 0.0 | (7.1) | (0.5) | (7.6) | (0.5) | (3.8) | (0.2) | (4.5) | ||
| Consumer Lifestyle | 9.3 | (5.5) | 0.0 | 3.8 | 10.8 | (2.5) | 0.0 | 8.3 | ||
| Lighting | 3.0 | (5.8) | 0.2 | (2.6) | 1.5 | (2.7) | 0.0 | (1.2) | ||
| Innovation, Group & | ||||||||||
| Services | (6.9) | (1.3) | 6.6 | (1.6) | (8.3) | (0.5) | 4.9 | (3.9) | ||
| Philips Group | 2.5 | (6.1) | 0.1 | (3.5) | 2.0 | (3.1) | 0.1 | (1.0) |
| 3rd quarter | January to September | |||||||
|---|---|---|---|---|---|---|---|---|
| Income from operations (or EBIT) |
Amortization of intangibles1) |
EBITA (or Adjusted income from operations) |
Income from operations (or EBIT) |
Amortization of intangibles1) |
EBITA (or Adjusted income from operations) |
|||
| 2013 | ||||||||
| Healthcare | 283 | (46) | 329 | 838 | (133) | 971 | ||
| Consumer Lifestyle | 102 | (14) | 116 | 255 | (41) | 296 | ||
| Lighting | 140 | (37) | 177 | 365 | (112) | 477 | ||
| Innovation, Group & Services |
(61) | (1) | (60) | (180) | (3) | (177) | ||
| Philips Group | 464 | (98) | 562 | 1,278 | (289) | 1,567 | ||
| 2012 | ||||||||
| Healthcare | 255 | (50) | 305 | 665 | (150) | 815 | ||
| Consumer Lifestyle | 63 | (15) | 78 | 287 | (42) | 329 | ||
| Lighting | (14) | (46) | 32 | 22 | (134) | 156 | ||
| Innovation, Group & | ||||||||
| Services | (50) | (1) | (49) | (150) | (6) | (144) | ||
| Philips Group | 254 | (112) | 366 | 824 | (332) | 1,156 |
1) Excluding amortization of software and product development
in millions of euros
| Philips Group | Healthcare | Consumer Lifestyle |
Lighting | IG&S | |
|---|---|---|---|---|---|
| September 29, 2013 | |||||
| Net operating capital (NOC) | 10,249 | 7,525 | 1,164 | 4,668 | (3,108) |
| Exclude liabilities comprised in NOC: | |||||
| - payables/liabilities |
9,335 | 2,730 | 1,565 | 1,851 | 3,189 |
| - intercompany accounts |
− | 159 | 79 | 126 | (364) |
| - provisions |
2,624 | 283 | 199 | 484 | 1,658 |
| Include assets not comprised in NOC: | |||||
| - investments in associates |
165 | 86 | − | 21 | 58 |
| - other current financial assets |
10 | − | − | − | 10 |
| - other non-current financial assets |
596 | − | − | − | 596 |
| - deferred tax assets |
1,826 | − | − | − | 1,826 |
| - cash and cash equivalents |
2,034 | − | − | − | 2,034 |
| 26,839 | 10,783 | 3,007 | 7,150 | 5,899 | |
| Assets classified as held for sale | 486 | ||||
| Total assets | 27,325 | ||||
| December 31, 2012 | |||||
| Net operating capital (NOC) | 9,316 | 7,976 | 1,205 | 4,635 | (4,500) |
| Exclude liabilities comprised in NOC: | |||||
| - payables/liabilities |
10,287 | 2,760 | 1,718 | 1,695 | 4,114 |
| - intercompany accounts |
− | 71 | 42 | 37 | (150) |
| - provisions |
2,956 | 355 | 315 | 581 | 1,705 |
| Include assets not comprised in NOC: | |||||
| - investments in associates |
177 | 86 | − | 22 | 69 |
| - other non-current financial assets |
549 | − | − | − | 549 |
| - deferred tax assets |
1,919 | − | − | − | 1,919 |
| - cash and cash equivalents |
3,834 | − | − | − | 3,834 |
| 29,038 | 11,248 | 3,280 | 6,970 | 7,540 | |
| Assets classified as held for sale | 43 | ||||
| Total assets | 29,081 | ||||
| September 30, 2012 | |||||
| Net operating capital (NOC) | 11,048 | 8,261 | 1,443 | 5,051 | (3,707) |
| Exclude liabilities comprised in NOC: | |||||
| - payables/liabilities |
9,855 | 2,920 | 1,703 | 1,792 | 3,440 |
| - intercompany accounts |
− | 68 | 32 | 54 | (154) |
| - provisions |
2,609 | 281 | 328 | 397 | 1,603 |
| Include assets not comprised in NOC: | |||||
| - investments in associates |
195 | 87 | − | 22 | 86 |
| - other non-current financial assets |
557 | − | − | − | 557 |
| - deferred tax assets |
1,837 | − | − | − | 1,837 |
| - cash and cash equivalents |
3,232 | − | − | − | 3,232 |
| 29,333 | 11,617 | 3,506 | 7,316 | 6,894 | |
| Assets held for sale | 56 | ||||
| Total assets | 29,389 |
in millions of euros
| September 30, | December 31, | September 29, | |
|---|---|---|---|
| 2012 | 2012 | 2013 | |
| Long-term debt | 3,837 | 3,725 | 3,374 |
| Short-term debt | 859 | 809 | 692 |
| Total debt | 4,696 | 4,534 | 4,066 |
| Cash and cash equivalents | 3,232 | 3,834 | 2,034 |
| Net debt (cash) (total debt less cash and cash equivalents) | 1,464 | 700 | 2,032 |
| Shareholders' equity | 12,016 | 11,151 | 10,913 |
| Non-controlling interests | 36 | 34 | 38 |
| Group equity | 12,052 | 11,185 | 10,951 |
| Net debt and group equity | 13,516 | 11,885 | 12,983 |
| Net debt divided by net debt and group equity (in %) | 11 | 6 | 16 |
| Group equity divided by net debt and group equity (in %) | 89 | 94 | 84 |
| 3rd quarter | January to September | ||||
|---|---|---|---|---|---|
| 2012 | 2013 | 2012 | 2013 | ||
| Cash flows provided by operating activities | 648 | 337 | 1,026 | 233 | |
| Cash flows used for investing activities | (274) | (231) | (609) | (672) | |
| Cash flows before financing activities | 374 | 106 | 417 | (439) | |
| Cash flows provided by operating activities | 648 | 337 | 1,026 | 233 | |
| Net capital expenditures: | (238) | (220) | (152) | (669) | |
| Purchase of intangible assets | (11) | (9) | (25) | (17) | |
| Proceeds from sale of intangible assets | − | − | 160 | − | |
| Expenditures on development assets | (86) | (88) | (250) | (268) | |
| Capital expenditures on property, plant and equipment | (144) | (137) | (449) | (406) | |
| Proceeds from sale of property, plant and equipment | 3 | 14 | 412 | 22 | |
| Free cash flows | 410 | 117 | 874 | (436) |
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.